uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
25.00
+0.49
(+2.00%)
Pre-Market: 09:28
uniQure Total Assets (Quarterly) : 985.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 985.10M |
| March 31, 2026 | 778.71M |
| December 31, 2025 | 824.91M |
| September 30, 2025 | 888.38M |
| June 30, 2025 | 584.89M |
| March 31, 2025 | 605.40M |
| December 31, 2024 | 556.54M |
| September 30, 2024 | 645.81M |
| June 30, 2024 | 730.85M |
| March 31, 2024 | 770.05M |
| December 31, 2023 | 831.69M |
| September 30, 2023 | 871.55M |
| June 30, 2023 | 942.77M |
| March 31, 2023 | 631.00M |
| December 31, 2022 | 704.96M |
| September 30, 2022 | 638.23M |
| June 30, 2022 | 701.21M |
| March 31, 2022 | 757.15M |
| December 31, 2021 | 809.18M |
| September 30, 2021 | 774.62M |
| June 30, 2021 | 784.26M |
| March 31, 2021 | 363.85M |
| December 31, 2020 | 340.40M |
| September 30, 2020 | 350.51M |
| June 30, 2020 | 385.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 414.24M |
| December 31, 2019 | 448.63M |
| September 30, 2019 | 471.59M |
| June 30, 2019 | 253.08M |
| March 31, 2019 | 268.99M |
| December 31, 2018 | 273.91M |
| September 30, 2018 | 281.06M |
| June 30, 2018 | 308.54M |
| March 31, 2018 | 192.24M |
| December 31, 2017 | 209.64M |
| September 30, 2017 | 138.99M |
| June 30, 2017 | 157.96M |
| March 31, 2017 | 181.43M |
| December 31, 2016 | |
| September 30, 2016 | 214.35M |
| June 30, 2016 | 230.88M |
| March 31, 2016 | 253.99M |
| December 31, 2015 | 263.00M |
| September 30, 2015 | 284.26M |
| June 30, 2015 | 256.76M |
| March 31, 2015 | 96.80M |
| December 31, 2014 | 115.91M |
| September 30, 2014 | 128.01M |
| June 30, 2014 | 139.28M |
| March 31, 2014 | 139.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Kymera Therapeutics, Inc. | 1.645B |
| Sarepta Therapeutics, Inc. | 3.189B |
| Twist Bioscience Corp. | 672.44M |
| GRAIL, Inc. | 2.844B |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 661.05M |
| Shareholders Equity (Quarterly) | 324.05M |
| Debt to Equity Ratio | 1.704 |
| Current Ratio | 10.01 |
| Net Debt Paydown Yield | -0.25% |